Quick Answer
GeneDx Holdings Corp. reported Operating Income of -$13.08 million for fiscal year 2025.
GeneDx Holdings Corp. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$13.08M | +43.7% |
| 2024 | -$23.21M | +87.1% |
| 2023 | -$180.60M | +73.0% |
| 2022 | -$667.65M | -49.6% |
| 2021 | -$446.15M | -84.4% |
| 2020 | -$241.99M | -695.7% |
| 2019 | -$30.41M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.25M | +58.2% | -136.3% |
| June 30, 2025 | $8.96M | +184.7% | +296.9% |
| March 31, 2025 | -$4.55M | +66.7% | +41.5% |
| September 30, 2024 | -$7.78M | +81.9% | +26.5% |
| June 30, 2024 | -$10.58M | +79.5% | +22.6% |
| March 31, 2024 | -$13.66M | +77.4% | +68.2% |
| September 30, 2023 | -$42.97M | +52.7% | +16.8% |
| June 30, 2023 | -$51.62M | +68.3% | +14.5% |
- GeneDx Holdings Corp. showed an increase of +43.7% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, GeneDx Holdings Corp.’s operating income has grown by 57.0% (from -$30.41 million to -$13.08 million).
- The most recent figure is from GeneDx Holdings Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: